Strategic Financial Concepts LLC Purchases Shares of 154,893 Stryker Co. (NYSE:SYK)

Strategic Financial Concepts LLC acquired a new position in shares of Stryker Co. (NYSE:SYK) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 154,893 shares of the medical technology company’s stock, valued at approximately $55,769,000. Stryker accounts for about 1.7% of Strategic Financial Concepts LLC’s holdings, making the stock its 3rd largest position.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Dunhill Financial LLC boosted its position in Stryker by 94.9% during the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 37 shares during the period. Darwin Wealth Management LLC bought a new stake in shares of Stryker during the third quarter valued at about $36,000. Activest Wealth Management acquired a new stake in Stryker in the fourth quarter worth about $36,000. Crews Bank & Trust bought a new position in Stryker in the 4th quarter valued at about $39,000. Finally, Hara Capital LLC acquired a new position in Stryker during the 3rd quarter valued at about $42,000. 77.09% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of the company’s stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares of the company’s stock, valued at $1,428,567,498. This represents a 5.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently issued reports on SYK. Stifel Nicolaus increased their price objective on shares of Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Wells Fargo & Company increased their price target on Stryker from $427.00 to $435.00 and gave the company an “overweight” rating in a research note on Wednesday, January 29th. Robert W. Baird boosted their price objective on Stryker from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Needham & Company LLC reaffirmed a “buy” rating and set a $442.00 target price on shares of Stryker in a research note on Wednesday, January 29th. Finally, Truist Financial boosted their price target on shares of Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a research report on Thursday, January 30th. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $420.68.

Stryker Stock Performance

Shares of SYK stock opened at $385.05 on Friday. The company has a market capitalization of $146.79 billion, a price-to-earnings ratio of 49.62, a P/E/G ratio of 2.98 and a beta of 0.96. Stryker Co. has a 1-year low of $314.93 and a 1-year high of $406.19. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The stock’s fifty day simple moving average is $377.31 and its 200-day simple moving average is $366.66.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the firm posted $3.46 EPS. On average, sell-side analysts predict that Stryker Co. will post 13.49 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s dividend payout ratio (DPR) is presently 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.